PHLDA2 antibody (C-Term)
Quick Overview for PHLDA2 antibody (C-Term) (ABIN6742130)
Target
See all PHLDA2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human PHLDA2
-
Predicted Reactivity
- Percent identity by BLAST analysis:
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human PHLDA2 (Q53GA4, NP_003302). Percent identity by BLAST analysis: Human, Gorilla (100%), Gibbon (92%), Marmoset (85%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1.0 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:1562500. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- PHLDA2 (Pleckstrin Homology-Like Domain, Family A, Member 2 (PHLDA2))
-
Alternative Name
- PHLDA2 / TSSC3
-
Background
-
Name/Gene ID: PHLDA2
Synonyms: PHLDA2, BWR1C, IPL, HLDA2, p17-BWR1C, BRW1C, TSSC3, Tumor-supressing STF cDNA 3 -
Gene ID
- 7262
-
NCBI Accession
- NP_003302
-
UniProt
- Q53GA4
-
Pathways
- Regulation of Carbohydrate Metabolic Process
Target
-